Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 144 No. 3334 (2014)

Vitamin D status among children and adolescents on anticonvulsant drugs in Southern Switzerland

  • Vera Ramelli
  • Gian Paolo Ramelli
  • Sebastiano A. G. Lava
  • Giordano M. Siegenthaler
  • Marco Cantù
  • Mario G. Bianchetti
  • Alessandro Ceschi
DOI
https://doi.org/10.4414/smw.2014.13996
Cite this as:
Swiss Med Wkly. 2014;144:w13996
Published
10.08.2014

Summary

INTRODUCTION: It is recognised that vitamin D status is often inadequate (<50 nmol/l) in epileptic children, mainly because some anticonvulsant drugs induce the enzymes responsible for its metabolism. The purpose of the present study was to address vitamin D status among children and adolescents treated with anticonvulsant drugs and control subjects who reside in southern Switzerland, a high solar radiation region.

METHODS: Between January and May 2013, total serum 25-hydroxyvitamin D was assessed by liquid chromatography-tandem mass spectrometry in 58 children and adolescents with epilepsy and 29 controls residing in southern Switzerland. Dark-skinned individuals, females wearing dress styles covering practically the whole body and subjects with body mass index ≥85th percentile for age and sex were excluded.

RESULTS: Concentration of serum 25-hydroxyvitamin D was similar in epilepsy patients (48 [37–62] nmol/l; median and interquartile range) and controls (53 [47–64] nmol/l). An inadequate serum 25-hydroxyvitamin D concentration was common both among patients (55%) and control subjects (34%). Serum 25-hydroxyvitamin D was significantly lower among patients treated with anticonvulsant drugs that induce the metabolism of vitamin D (30 [21–51] nmol/l) than among the remaining patients (51 [40–65] nmol/l) and controls.

CONCLUSIONS: The present study indicates a relevant tendency towards inadequate vitamin D status among children with and without anticonvulsant drug management who reside in southern Switzerland. This tendency is more prominent in patients treated with anticonvulsant drugs that induce the metabolism of 25-hydroxyvitamin D.

References

  1. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398–417.
  2. Wacker M, Holick MF. Vitamin D – effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–48.
  3. Shaw NJ, Mughal MZ. Vitamin D and child health part 1 (skeletal aspects). Arch Dis Child. 2013;98:363–7.
  4. Shaw NJ, Mughal MZ. Vitamin D and child health: part 2 (extraskeletal and other aspects). Arch Dis Child. 2013;98:368–72.
  5. Lava SA, Simonetti GD, Bianchetti AA, Ferrarini A, Bianchetti MG. Prevention of vitamin D insufficiency in Switzerland: A never-ending story. Int J Pharm. 2013;457:353–6.
  6. Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. BMJ. 1971;263:202–4.
  7. Sheth RD. Metabolic concerns associated with antiepileptic medications. Neurology. 2004;63(Suppl 4):S24–9.
  8. Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47:510–5.
  9. Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatr Neurol. 2010;43:320–4.
  10. Wirrell E. Vitamin D and bone health in children with epilepsy: fad or fact? Pediatr Neurol. 2010;42:394–5.
  11. Cantù M, Keller F. Vitamin D LC-MS/MS: optimization of chromatographic parameters to increased 60% of commercial kit througput. Biochim Clin. 2013;37:S442.
  12. Brown GW, Hayden GF. Nonparametric methods. Clinical applications. Clin Pediatr (Phila). 1985;24:490–8.
  13. Hollis BW. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab. 2004;89:3149–51.
  14. Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M; Swiss Survey on Salt Group. Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly. 2012;142:w13719.
  15. Fong CY, Riney CJ. Vitamin D deficiency among children with epilepsy in South Queensland. J Child Neurol. 2014;29:368–73.
  16. Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P, Massimetti G, Federico G, Saggese G. Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. Eur J Pediatr. 2013;172:1607–17.
  17. Janner M, Ballinari P, Mullis PE, Flück CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly. 2010;140:w13091.
  18. Stoll D, Lamy O, Hans D, Zufferey P, So A, Krieg MA, Aubry-Rozier B. Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study. Swiss Med Wkly. 2013;143:w13891.

Most read articles by the same author(s)